January 24, 2023
Prime Minister Fumio Kishida Prime Minister Fumio Kishida on January 23 applauded the accelerated approval of Eisai’s Alzheimer’s disease (AD) drug lecanemab in the US and expressed the government’s readiness to support R&D investments in biotechnology and other strategic fields...read more